Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis

Liver

Volumn 20, Issue 3, 2000, Pages 262-266

  Rambaldi, A ^a   Gluud, Christian ^b  

^a Loreto Mare Hospital   (Italy)

^b Mental Health Services CPH   (Denmark)

Author keywords

Alcoholic; Cirrhosis; Colchicine; Fibrosis; Non alcoholic

Indexed keywords

ALKALOID; COLCHICINE;

ALCOHOL CONSUMPTION; ARTICLE; CELL MIGRATION; CLINICAL TRIAL; DRUG EFFECT; GRANULOCYTE; HEPATITIS B; HEPATITIS C; HUMAN; ITALY; LIVER CIRRHOSIS; LIVER FIBROSIS; META ANALYSIS; RISK;

COLCHICINE; EVIDENCE-BASED MEDICINE; HUMANS; LIVER CIRRHOSIS, ALCOHOLIC; META-ANALYSIS; RANDOMIZED CONTROLLED TRIALS;

EID: 0034044971     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0676.2000.020003262.x     Document Type: Article

References (35)

1. CORRAO G, ZAMBON A, TORCHIO P, ARICO S, LA VECCHIA C, DI IORIO F. Attributable risk for symptomatic liver cirrhosis in Italy. Collaborative Groups for the Study of Liver Diseases in Italy. J Hepatol 1998; 28: 608-14.
2. nd ed. 1999: II: 1185-238.
3. RUBIN E, LIEBER C S. Alcohol-induced hepatic injury in non alcoholic volunteers. N Engl J Med 1968; 278: 869-76.
4. HILL D B, MARSANO L S, MCCLAIN C J. Increased plasma interleukin-8 concentrations in alcoholic hepatitis. Hepatology 1993; 18: 576-80.
5. SHERON N, BIRD G, KOSKINAS J, et al. Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration. Hepatology 1993; 18: 41-6.
6. SØRENSEN T I A, ORHOLM M, BENTSEN K D, HØYBYE G, EGHØJE K, CHRISTOFFERSEN P. Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis. Lancet 1984; 2: 241-4.
7. MARBET U A, BIANCHI L, MEURY U, STALDER G A. Long-term histological evaluation of the natural history and prognostic factors of alcoholic liver disease. J Hepatol 1987; 4: 364-72.
8. MENDENHALL C L, ANDERSON S, GARCIA-PONT P, et al. Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. N Engl J Med 1984; 311: 1464-70.
9. POWELL W J JR, KLATSKIN G. Duration of survival in patients with Laennec's cirrhosis. Influence of alcohol withdrawal, and possible effects of recent changes in general management of the disease. Am J Med 1968; 44: 406-20.
10. CHANG T T, LIN C Y, CHOW N H, et al. Hepatitis B and hepatitis C virus infection among chronic alcoholic patients with liver disease in Taiwan. J Formos Med Assoc 1994; 93: 128-33.
11. CORRAO G, ARICO S. Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis. Hepatology 1998; 27: 914-9.
12. IMPERIAE J C. Natural history of chronic hepatitis B and C. J Gastroenterol Hepatol 1999; 14: S1-5.
13. POYNARD T, BEDOSSA P, OPOLON P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 1997; 349: 825-32.
14. WILEY T E, MCCARTHY M, BREIDI L, MCCARTHY M, LAYDEN T J. Impact of alcohol on the histological and clinical progression of hepatitis C infection. Hepatology 1998; 28: 805-9.
15. SCHIFF E R. Hepatitis C and alcohol. Hepatology 1997; 26: 39S-42S.
16. CHEVILOTTE G, DURBEC J P, GEROLAMI A, BERTHEZENE P, BIDART J M, CAMATTE R. Interaction between hepatitis B virus and alcohol consumption in liver cirrhosis. An epidemiological study. Gastroenterology 1983; 85: 141-5.
17. BEN-CHETRIT E, LEVY M. Colchicine: 1998 update. Semin Arthritis Rheum 1998; 28: 48-59.
18. SHI Q, CHEN K, MORRIS-NATSCHKE, LEE K H. Recent progress in the development of tubulin inhibitors as antimitotic antitumor agents. Curr Pharm Des 1998; 4: 219-48.
19. EHRLICH HP, BORNSTEIN P. Microtubules in transcellular movement of procollagen. Nature New Biol 1972; 238: 257-60.
20. HARRIS E D, KRANE S M. Effects of colchicine on collagenase in cultures of rheumatoid synovium. Arthritis Rheum 1971; 14: 669-84.
21. ROJKIND M, KERSHENOBICH D. Effect of colchicine on collagen, albumin and transferrin synthesis by cirrhotic rat liver slices. Biochim Biophys Acta 1975; 378: 415-23.
22. TRINCHET J C, BEAUGRAND M, CALLARD P, et al. Treatment of alcoholic hepatitis with colchicine. Results of a double blind randomized trial. Gastroenterol Clin Biol 1989; 13: 551-5.
23. AKRIVIADIS E A, STEINDEL H, PINTO P C, FONG T-L, KANEL G, REYNOLDS T B. Failure of colchicine to improve short-term survival in patients with alcoholic hepatitis. Gastroenterology 1990; 99: 811-8.
24. COLMAN J C, CROMIE S L, COX J M, ROBERTS S K, DUDLEY E, DUDLEY F J. The natural history of alcoholic cirrhosis: effect of colchicine. Hepatology 1998; 28: 510A.
25. KERSHENOBICH D, GARCÍA-TSAO G, SALDANA S A, ROJKIND M. Relationship between blood lactic acid and serum proline in alcoholic liver cirrhosis. Gastroenterology 1981; 80: 1012-5.
26. KERSHENOBICH D, VARGAS F, GARCIA-TSAO G, TAMAYO R P, GENT M, ROJKIND M. Colchicine in the treatment of cirrhosis of the liver. N Engl J Med 1988; 318: 1709-13.
27. GLUUD C, AFROUDAKIS A, CABALLERIA J, et al. Diagnosis and treatment of alcoholic liver disease in Europe. Gastroenterology International 1993; 6: 221-30.
28. WARNES T W. Colchicine in primary biliary cirrhosis. Aliment Pharmacol Ther 1991; 5: 321-79.
29. SACKS H S, BERRIER J, REITMAN D, ANCONA-BERK V A, CHALMERS T C. Meta-analyses of randomized controlled trials. N Engl J Med 1987; 316: 450-5.
30. JADAD A R, MOORE R A, CARROLL D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12.
31. DERSIMONIAN R, LAIRD N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
32. DEMETS D L. Pratical aspects in monitoring: a brief review. Stat Med 1987; 6: 753-60.
33. MOHER D, PHAM B, JONES A, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses. Lancet 1998; 352: 609-13.
34. KJAERGARD L L, VILLUMSEN J, GLUUD C. Quality of randomised clinical trials affects estimates of intervention efficacy (abstract): VII Cochrane Colloquium (Rome) 1999: 57.
35. GLUUD C. "Negative trials" are positive! J Hepatol 1998; 28: 731-3.